benzyl N2-(tert-butoxycarbonyl)-N5,N5-bis(2-((tert-butoxycarbonyl)amino)ethyl)-L-glutaminate

Catalog No. :
ACPAVO298
CAS No. :
1226867-77-1
Molecular Formula :
C31H50N4O9
Molecular Weight :
622.76

IUPAC Name:benzyl N2-(tert-butoxycarbonyl)-N5,N5-bis(2-((tert-butoxycarbonyl)amino)ethyl)-L-glutaminate

benzyl N2-(tert-butoxycarbonyl)-N5,N5-bis(2-((tert-butoxycarbonyl)amino)ethyl)-L-glutaminate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namebenzyl N2-(tert-butoxycarbonyl)-N5,N5-bis(2-((tert-butoxycarbonyl)amino)ethyl)-L-glutaminate
IUPAC Namebenzyl N2-(tert-butoxycarbonyl)-N5,N5-bis(2-((tert-butoxycarbonyl)amino)ethyl)-L-glutaminate
Molecular FormulaC31H50N4O9
Molecular Weight622.76
SMILESCC(C)(C)OC(=O)NCCN(CCNC(=O)OC(C)(C)C)C(=O)CC[C@H](NC(=O)OC(C)(C)C)C(=O)OCC1=CC=CC=C1
InChI KeyJSFJNYPYJMASBA-QHCPKHFHSA-N
SynonymBenzyl N2-(tert-butoxycarbonyl)-N5,N5-bis(2-((tert-butoxycarbonyl)amino)ethyl)-L-glutaminate;1,1-Dimethylethyl (9S)-5-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-13,13-dimethyl-6,11-dioxo-9-[(phenylmethoxy)carbonyl]-12-oxa-2,5,10-triazatetradecanoate
CAS No.1226867-77-1

Synthetic Route by SureRoute

1. ACPAVO298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCMZV589 route compound structure diagram
    ACCMZV589117499-16-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPAVO298 route product structure diagram
    ACPAVO2981226867-77-1
Inquiry

2. ACPAVO298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCMZV589 route compound structure diagram
    ACCMZV589117499-16-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPAVO298 route product structure diagram
    ACPAVO2981226867-77-1
Inquiry

Comments (0)